Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
CVS shares are up 45% this year — here's why it may be starting to turn its business around
02:14pm, Thursday, 13'th Feb 2025
CVS Health could be starting to turn itself around after a dismal 2024. Its shares are up more than 45% this year, outperforming pharmacy rival Walgreens and other insurers like UnitedHealth Group and
CVS wins upgrade to buy as analyst sees more upside potential than its peers
12:05pm, Thursday, 13'th Feb 2025
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.
CVS Health: Earnings Beat Ignites Stock Rally
09:00am, Thursday, 13'th Feb 2025
Shares of CVS Health Corporation NYSE: CVS experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's sto
These Analysts Boost Their Forecasts On CVS Health Following Upbeat Earnings
08:48am, Thursday, 13'th Feb 2025
CVS Health Corp CVS reported upbeat earnings for its fourth quarter on Wednesday.
CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
07:30am, Thursday, 13'th Feb 2025
Despite a >10% rise in CVS Health's stock price from my initial BUY recommendation, CVS Health is downgraded to Hold due to substantial political risks and declining cash flow. CVS faces significant c
S&P 500 Gains and Losses Today: CVS Stock Jumps as Pharmacy Segment Delivers Growth
04:45pm, Wednesday, 12'th Feb 2025
Major U.S. equities indexes were mixed on Wednesday as the latest Consumer Price Index (CPI) data showed an unexpected uptick in inflation during January.
Nasdaq Edges Higher; CVS Health Shares Jump Following Upbeat Earnings
02:42pm, Wednesday, 12'th Feb 2025
U.S. stocks traded mostly lower toward the end of trading, while the Nasdaq Composite edged higher on Wednesday.
CVS CEO defends pharmacy middlemen, accuses drugmakers of 'monopolistic' practices
01:37pm, Wednesday, 12'th Feb 2025
CVS Health CEO David Joyner defended controversial pharmacy middlemen, who are widely accused of inflating prescription medication prices, and instead accused manufacturers of "monopolistic" practices
Trade Tracker: Joe Terranova buys CVS and Alibaba
01:14pm, Wednesday, 12'th Feb 2025
Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to explain why he's buying these two stocks at these levels.
CVS shares move higher on upbeat Q4 report
12:25pm, Wednesday, 12'th Feb 2025
CVS Health Corp (NYSE:CVS)'s shares surged more than 15% after the pharmacy chain posted positive financial results for the fourth quarter. Adjusted earnings per share of $1.19 on revenue of $97.71 bi
Why CVS Health Stock Popped Today
11:54am, Wednesday, 12'th Feb 2025
Shares of CVS Health (CVS 13.66%) were soaring Wednesday after the diversified healthcare giant's fourth-quarter results topped estimates and management offered better-than-expected guidance for 2025.
CVS Beats EPS Estimates, Losses Loom
11:53am, Wednesday, 12'th Feb 2025
CVS Health (CVS 13.34%), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 earnings on February 12, 2025.
CVS Health (CVS) Q4 2024 Earnings Call Transcript
11:27am, Wednesday, 12'th Feb 2025
CVS Health (CVS) Q4 2024 Earnings Call Transcript
3 Stocks Bucking Inflation Headwinds After Earnings
11:11am, Wednesday, 12'th Feb 2025
Hotter-than-expected inflation data is pressuring stocks this morning, but the shares of CVS Health Corp (NYSE:CVS), DoorDash Inc (NASDAQ:DASH), and Upstart Holdings Inc (NASDAQ:UPST) are bucking to
CVS Health (CVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
10:36am, Wednesday, 12'th Feb 2025
The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street est
